Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery

Breast Cancer Research

Volumn 17, Issue 1, 2015, Pages

  Kossatz, Susanne ^a   Grandke, Julia ^a   Couleaud, Pierre ^b,e   Latorre, Alfonso ^b,e   Aires, Antonio ^b,e   Crosbie Staunton, Kieran ^c   Ludwig, Robert ^a   Dähring, Heidi ^a   Ettelt, Volker ^a   Lazaro Carrillo, Ana ^d   Calero, Macarena ^b,d   Sader, Maha ^f   Courty, José ^f   Volkov, Yuri ^c,g   Prina Mello, Adriele ^c,g   Villanueva, Angeles ^b,d   Somoza, Álvaro ^b,e   Cortajarena, Aitziber L ^b,e   Miranda, Rodolfo ^b,e   Hilger, Ingrid ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b INSTITUTO MADRILEÑO DE ESTUDIOS AVANZADOS EN NANOCIENCIA IMDEA NANOCIENCIA   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^f UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^g TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; IRON OXIDE NANOPARTICLE; NANOPARTICLE; PSEUDOPEPTIDE; SUCCIMER; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; FERRIC ION; FERRIC OXIDE; METAL NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BREAST ADENOCARCINOMA; CANCER INHIBITION; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; CELLULAR DISTRIBUTION; CLINICAL PRACTICE; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMIDIFIER; HYDRODYNAMICS; HYPERTHERMIA; INTERNALIZATION; LYSOSOME; MAGNETIC FIELD; MAGNETIC HYPERTHERMIA; MASS SPECTROMETRY; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; PARTICLE SIZE; SENSITIVITY ANALYSIS; THERMOGRAPHY; TUMOR GROWTH; TUMOR VOLUME; VASCULARIZATION; ZETA POTENTIAL; ADVERSE EFFECTS; ANIMAL; APOPTOSIS; BREAST NEOPLASMS; CHEMISTRY; DISEASE MODEL; DRUG RELEASE; DRUG SCREENING; NUDE MOUSE; PATHOLOGY; PROCEDURES; THERMOTHERAPY; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FEMALE; FERRIC COMPOUNDS; HUMANS; HYPERTHERMIA, INDUCED; METAL NANOPARTICLES; MICE; MICE, NUDE; X-RAY MICROTOMOGRAPHY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84930627293     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/s13058-015-0576-1     Document Type: Article

References (40)

1. Guo J, Gao X, Su L, Xia H, Gu G, Pang Z, et al. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery. Biomaterials. 2011;32:8010-20.
2. Fang C, Veiseh O, Kievit F, Bhattarai N, Wang F, Stephen Z, et al. Functionalization of iron oxide magnetic nanoparticles with targeting ligands: their physicochemical properties and in vivo behavior. Nanomed. 2010;5:1357-69.
3. Ding Y, Zhou YY, Chen H, Geng DD, Wu DY, Hong J, et al. The performance of thiol-terminated PEG-paclitaxel-conjugated gold nanoparticles. Biomaterials. 2013;34:10217-27.
4. Kim JE, Shin JY, Cho MH. Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects. Arch Toxicol. 2012;86:685-700.
5. Yoo D, Lee JH, Shin TH, Cheon J. Theranostic magnetic nanoparticles. Acc Chem Res. 2011;44:863-74.
6. Chatterjee DK, Diagaradjane P, Krishnan S. Nanoparticle-mediated hyperthermia in cancer therapy. Ther Deliv. 2011;2:1001-14.
7. Dutz S, Hergt R. Magnetic nanoparticle heating and heat transfer on a microscale: Basic principles, realities and physical limitations of hyperthermia for tumour therapy. Int J Hyperthermia. 2013;29:790-800.
8. Glöckl G, Hergt R, Zeisberger M, Dutz S, Nagel S, Weitschies W. The effect of field parameters, nanoparticle properties and immobilization on the specific heating power in magnetic particle hyperthermia. J Phys Condens Matter. 2006;18:S2935-49.
9. Hilger I. In vivo applications of magnetic nanoparticle hyperthermia. Int J Hyperthermia. 2013;29:828-34.
10. Kettering M, Richter H, Wiekhorst F, Bremer-Streck S, Trahms L, Kaiser WA, et al. Minimal-invasive magnetic heating of tumors does not alter intra-tumoral nanoparticle accumulation, allowing for repeated therapy sessions: an in vivo study in mice. Nanotechnology. 2011;22:505102.
11. Hu R, Ma S, Li H, Ke X, Wang G, Wei D, et al. Effect of magnetic fluid hyperthermia on lung cancer nodules in a murine model. Oncol Lett. 2011;2:1161-4.
12. Huang HS, Hainfeld JF. Intravenous magnetic nanoparticle cancer hyperthermia. Int J Nanomedicine. 2013;8:2521-32.
13. Latorre A, Couleaud P, Aires A, Cortajarena AL, Somoza A. Multifunctionalization of magnetic nanoparticles for controlled drug release: A general approach. Eur J Med Chem. 2014;82:355-62.
14. Yoo D, Jeong H, Preihs C, Choi JS, Shin TH, Sessler JL, et al. Double-effector nanoparticles: a synergistic approach to apoptotic hyperthermia. Angew Chem Int Ed Engl. 2012;51:12482-5.
15. Destouches D, El Khoury D, Hamma-Kourbali Y, Krust B, Albanese P, Katsoris P, et al. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. Plos One. 2008;3:E2518.
16. Destouches D, Huet E, Sader M, Frechault S, Carpentier G, Ayoul F, et al. Multivalent pseudopeptides targeting cell surface nucleoproteins inhibit cancer cell invasion through tissue inhibitor of metalloproteinases 3 (TIMP-3) release. J Biol Chem. 2012;287:43685-93.
17. Krust B, El Khoury D, Nondier I, Soundaramourty C, Hovanessian AG. Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type. BMC Cancer. 2011;11:333.
18. Destouches D, Page N, Hamma-Kourbali Y, Machi V, Chaloin O, Frechault S, et al. A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins. Cancer Res. 2011;71:3296-305.
19. Oliveira H, Perez-Andres E, Thevenot J, Sandre O, Berra E, Lecommandoux S. Magnetic field triggered drug release from polymersomes for cancer therapeutics. J Control Release. 2013;169:165-70.
20. Anirudhan TS, Sandeep S. Synthesis, characterization, cellular uptake and cytotoxicity of a multifunctional magnetic nanocomposite for the targeted delivery and controlled release of doxorubicin to cancer cells. J Mater Chem. 2012;22:12888-99.
21. Kaaki K, Herve-Aubert K, Chiper M, Shkilnyy A, Souce M, Benoit R, et al. Magnetic nanocarriers of doxorubicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties, colloidal stability, and cancer cell targeting. Langmuir. 2012;28:1496-505.
22. Li L, ten Hagen TL, Hossann M, Suss R, van Rhoon GC, Eggermont AM, et al. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. J Control Release. 2013;168:142-50.
23. Yarmolenko PS, Zhao Y, Landon C, Spasojevic I, Yuan F, Needham D, et al. Comparative effects of thermosensitive doxorubicin-containing liposomes and hyperthermia in human and murine tumours. Int J Hyperthermia. 2010;26:485-98.
24. Zhang J, Misra RDK. Magnetic drug-targeting carrier encapsulated with thermosensitive smart polymer: Core-shell nanoparticle carrier and drug release response. Acta Biomater. 2007;3:838-50.
25. Chang BS, Guo J, Liu CY, Qian J, Yang WL. Surface functionalization of magnetic mesoporous silica nanoparticles for controlled drug release. J Mater Chem. 2010;20:9941-7.
26. Reimers GW, Khalafalla SE. Preparing magnetic fluids by a peptizing method. In: US Bureau of Mines, Tech Prog Rep 59. 1972.
27. Salas G, Casado C, Teran FJ, Miranda R, Serna CJ, Morales MP. Controlled synthesis of uniform magnetite nanocrystals with high-quality properties for biomedical applications. J Mater Chem. 2012;22:21065-75.
28. Kossatz S, Ludwig R, Dahring H, Ettelt V, Rimkus G, Marciello M, et al. High Therapeutic Efficiency of Magnetic Hyperthermia in Xenograft Models Achieved with Moderate Temperature Dosages in the Tumor Area. Pharm Res. 2014;31:3274-88.
29. Prina-Mello A, Crosbie-Staunton K, Salas G, Morales MD, Volkov Y. Multiparametric Toxicity Evaluation of SPIONs by High Content Screening Technique: Identification of Biocompatible Multifunctional Nanoparticles for Nanomedicine. IEEE Trans Magn. 2013;49:377-82.
30. Gonzalez RJ, Tarloff JB. Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicol In Vitro. 2001;15:257-9.
31. Sapareto SA, Dewey WC. Thermal dose determination in cancer therapy. Int J Radiat Oncol Biol Phys. 1984;10:787-800.
32. Kallumadil M, Tada M, Nakagawa T, Abe M, Southern P, Pankhurst QA. Suitability of commercial colloids for magnetic hyperthermia. J Magn Magn Mater. 2009;321:1509-13.
33. Cervadoro A, Giverso C, Pande R, Sarangi S, Preziosi L, Wosik J, et al. Design maps for the hyperthermic treatment of tumors with superparamagnetic nanoparticles. Plos One. 2013;8:e57332.
34. Hergt R, Andra W, d'Ambly CG, Hilger I, Kaiser WA, Richter U, et al. Physical limits of hyperthermia using magnetite fine particles. IEEE Trans Magn. 1998;34:3745-54.
35. Dutz S, Kettering M, Hilger I, Muller R, Zeisberger M. Magnetic multicore nanoparticles for hyperthermia-influence of particle immobilization in tumour tissue on magnetic properties. Nanotechnology. 2011;22:265102.
36. Richter H, Kettering M, Wiekhorst F, Steinhoff U, Hilger I, Trahms L. Magnetorelaxometry for localization and quantification of magnetic nanoparticles for thermal ablation studies. Phys Med Biol. 2010;55:623-33.
37. Elsherbini AAM, El-Shahawy A. Effect of SPIO nanoparticle concentrations on temperature changes for hyperthermia via MRI. J Nanomater. 2013: 467878
38. Goldberg EP, Hadba AR, Almond BA, Marotta JS. Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery. J Pharm Pharmacol. 2002;54:159-80.
39. Wang J, Chen Y, Chen B, Ding J, Xia G, Gao C, et al. Pharmacokinetic parameters and tissue distribution of magnetic Fe(3)O(4) nanoparticles in mice. Int J Nanomedicine. 2010;5:861-6.
40. Yallapu MM, Ebeling MC, Khan S, Sundram V, Chauhan N, Gupta BK, et al. Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Mol Cancer Ther. 2013;12:1471-80.